DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers
Clinical trial NCT06132113 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06132113
- Sponsor
- Boehringer Ingelheim
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-22
- Primary completion
- 2027-10-09
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.